Pee Cee Cosma Sope schedules 39th AGM for September 29, 2026

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Pee Cee Cosma Sope schedules its 39th AGM for September 29, 2026, in Agra
  • Shareholders to adopt FY26 financial statements and approve a ₹3 per share final dividend
  • Managing Director Ankit Jain seeks re-appointment; holds 9.44% stake
  • Remuneration for Cost Auditors M/s Dileep Verma & Associates set at ₹35,000 annually
  • Remote e-voting opens on September 26, 2026, with a record date of September 21
powered bylight_fuzz_icon
49890282

*this image is generated using AI for illustrative purposes only.

Pee Cee Cosma Sope has scheduled its 39th Annual General Meeting for Tuesday, September 29, 2026. The meeting will convene at Hotel Holiday Inn in Agra at 3:00 pm to address ordinary and special business items for shareholders.

Meeting Agenda

The Board of Directors has outlined the following key resolutions for shareholder approval:

  • Adoption of the Audited Standalone and Consolidated Financial Statements for FY26.
  • Declaration of a final dividend of ₹3 per equity share (30%).
  • Re-appointment of Ankit Jain as a director, who retires by rotation.
  • Ratification of remuneration for Cost Auditors for FY27.

Corporate Governance Details

Ankit Jain, Managing Director, seeks re-appointment after retiring by rotation. He holds a shareholding of 2,49,914 equity shares, representing 9.44% of the company's capital. His monthly remuneration is fixed at ₹2,80,000. The disclosure notes he has attended four Board meetings during FY26.

The Board has recommended ratifying the remuneration of M/s Dileep Verma & Associates, Cost Accountants, for auditing cost records in FY27. The approved fee is ₹35,000 per annum plus applicable taxes and reimbursement of out-of-pocket expenses.

Voting and Record Dates

Shareholders holding shares as on the record date of Monday, September 21, 2026, are eligible to vote. Remote e-voting facilities via NSDL will be available from Saturday, September 26, 2026, at 9:00 am until Monday, September 28, 2026, at 5:00 pm. The Register of Members and Share Transfer Books will remain closed from September 22, 2026, to September 29, 2026.

CS Debabrata Deb Nath has been appointed as the Scrutinizer to oversee the e-voting process. Results will be declared within 48 hours of the meeting's conclusion.

Historical Stock Returns for Pee Cee Cosma Sope

1 Day5 Days1 Month6 Months1 Year5 Years
+0.40%-1.66%+20.71%+21.94%-8.74%+198.59%

How does the proposed 30% dividend payout ratio compare to Pee Cee Cosma Sope's historical averages, and what does this signal about the company's cash flow health and future growth reinvestment strategy?

Given Ankit Jain's re-appointment and significant shareholding, what specific strategic initiatives or performance targets has management outlined for FY27 to justify continued shareholder confidence?

What are the primary drivers behind the financial results presented in the FY26 audited statements, and how do they position the company against competitors in the Agra-based manufacturing sector?

Pee Cee Cosma Sope Q1FY26 net profit up 12.6% to ₹335 lakh

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Pee Cee Cosma Sope posted a 12.6% YoY rise in Q1FY26 standalone net profit to ₹335.16 lakh, driven by 19.1% revenue growth. Consolidated profit rose 11.9% to ₹325.27 lakh. The Board approved ₹5 crore infusions into Pee Cee Energy and Abhaya Nourishtech.

powered bylight_fuzz_icon
48099022

*this image is generated using AI for illustrative purposes only.

Pee Cee Cosma Sope reported a 12.6% year-on-year rise in standalone net profit to ₹335.16 lakh for the quarter ended June 30, 2026 (Q1FY26), driven by a 19.1% increase in revenue from operations to ₹4,742.92 lakh. Consolidated net profit rose 11.9% to ₹325.27 lakh, with consolidated revenue reaching ₹4,928.20 lakh, up 23.4% from the same period last year.

The company’s Board of Directors, in a meeting held on August 12, 2026, approved the unaudited standalone and consolidated financial results for the quarter. The Board also authorized capital infusions of up to ₹5 crore each into two wholly owned subsidiaries: Pee Cee Energy and Reality Ltd and Abhaya Nourishtech Ltd. These investments aim to address working capital needs and support business expansion in the energy, infrastructure, and nutraceutical segments.

Financial Performance

Standalone revenue from operations grew to ₹4,742.92 lakh in Q1FY26, compared to ₹3,980.98 lakh in Q1FY25. Other income stood at ₹123.56 lakh, reversing a loss of ₹146.66 lakh in the preceding quarter. Total expenses rose to ₹4,407.23 lakh from ₹3,664.20 lakh a year ago, primarily due to higher cost of materials consumed at ₹3,786.29 lakh.

Metric Q1FY26 Q1FY25 Change
Revenue from Operations (Standalone) ₹4,742.92 lakh ₹3,980.98 lakh +19.1%
Net Profit (Standalone) ₹335.16 lakh ₹298.56 lakh +12.6%
Revenue from Operations (Consolidated) ₹4,928.20 lakh ₹3,995.17 lakh +23.4%
Net Profit (Consolidated) ₹325.27 lakh ₹290.55 lakh +11.9%

Consolidated other income was ₹123.56 lakh. Finance costs remained minimal at ₹5.48 lakh, while depreciation and amortization expenses totaled ₹36.30 lakh. The effective tax rate for the quarter resulted in total tax expenses of ₹125.74 lakh on a consolidated basis.

What the Numbers Show

The divergence between the 19.1% standalone revenue growth and the 12.6% net profit growth indicates margin compression in the core manufacturing segment. While top-line expansion was robust, the cost of materials consumed rose disproportionately, increasing from ₹2,892.81 lakh in Q1FY25 to ₹3,786.29 lakh in Q1FY26. This suggests that input cost inflation or volume mix shifts may be exerting pressure on operating leverage, despite the overall improvement in profitability.

Strategic Investments

The Board approved additional equity share acquisitions in its subsidiaries to strengthen liquidity and operational capacity:

  • Pee Cee Energy and Reality Ltd: Investment of up to ₹5 crore for energy and infrastructure-related activities. The subsidiary has nil turnover as it was incorporated recently.
  • Abhaya Nourishtech Ltd: Investment of up to ₹5 crore for milk proteins, plant proteins, and nutraceutical ingredients. The subsidiary reported a turnover of ₹1.62 crore.

These moves align with the group’s strategy to diversify beyond its primary laundry soap and detergent manufacturing business into infrastructure, energy, and nutritional ingredients. The 39th Annual General Meeting is scheduled for September 29, 2026.

Historical Stock Returns for Pee Cee Cosma Sope

1 Day5 Days1 Month6 Months1 Year5 Years
+0.40%-1.66%+20.71%+21.94%-8.74%+198.59%

How does Pee Cee Cosma plan to mitigate the margin compression caused by the disproportionate rise in material costs relative to revenue growth?

What specific milestones or revenue targets are expected from Pee Cee Energy and Reality Ltd following the ₹5 crore capital infusion, given its current nil turnover status?

Will the expansion into nutraceuticals via Abhaya Nourishtech Ltd require significant additional capex beyond the approved ₹5 crore to achieve operational scale?

More News on Pee Cee Cosma Sope

1 Year Returns:-8.74%